December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved sensitivity for the detection of cardiac ischemia by more than 50 percent (p

December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging systems and advanced photonic components, as part of Volcano’s strategy to establish its position in invasive imaging.

December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved the detection of cardiac ischemia by more than 50 percent greater than the standard of care when compared to the standard of care alone.

December 29, 2008 - Calgary Scientific Inc. plans to release its ResolutionMD Cardiac advanced visualization suite of ...

December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement to acquire Axsun Technologies Inc., a privately-held company that is a developer and manufacturer of lasers and optical engines used in medical optical coherence tomography (OCT) imaging systems and advan

December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB for $250 million in cash.